Related Experiment Video
Updated: May 23, 2026

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
Published on: December 17, 2014
Effects of neural progenitor cell transplantation in children with severe cerebral palsy
Zuo Luan1, Weipeng Liu, Suqing Qu
1Department of Pediatrics, Navy General Hospital, No. 6 Fucheng Road, Beijing, P.R. China. luanzuo@yahoo.com.cn
Insights
Neural progenitor cell (NPC) transplantation shows promise for severe cerebral palsy (CP). This therapy safely improved motor and cognitive functions in children with severe CP after one year.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Pediatric Neurology
Background:
- Cerebral palsy (CP) is a chronic neurological disorder impacting children's physical and developmental health.
- Current treatments offer limited benefits for severe CP cases.
- Effective interventions for severe CP remain a critical unmet need.
Purpose of the Study:
- To evaluate the safety and efficacy of neural progenitor cell (NPC) transplantation for treating severe CP in children.
- To assess the impact of NPC transplantation on neurological function and motor development.
Main Methods:
- NPCs derived from aborted fetal tissue were transplanted into the lateral ventricle of 45 children with severe CP.
- Neurological function was assessed using Gross Motor Function Measures (GMFM), Peabody Developmental Motor Scale-Fine Motor (PDMS-FM) test, and a CP-specific questionnaire.
- A control group was used for comparison.
Main Results:
- Significant acceleration in motor development was observed within the first month post-transplantation.
- While the initial rapid improvement slowed, developmental levels in gross motor, fine motor, and cognitive spheres were significantly higher in the treatment group after one year compared to controls.
- No delayed complications were reported.
Conclusions:
- NPC transplantation is a safe and effective therapeutic approach for children suffering from severe CP.
- This innovative treatment offers a potential new avenue for improving long-term outcomes in severe pediatric neurological conditions.
Abstract:
Cerebral palsy (CP) is a chronic nervous system disease that severely damages the physical and developmental health of children. Traditional treatment brings about only improvement of mild to moderate CP, but severe CP still lacks effective interventions. To explore safety and efficacy of using neural progenitor cells (NPCs) to treat CP in children, we performed NPC transplantation in 45 patients with severe CP by injecting NPCs derived from aborted fetal tissue into the lateral ventricle. Gross motor function measures (GMFM), the Peabody Developmental Motor Scale-Fine Motor (PDMS-FM) test, and a unified survey questionnaire designed specifically for children with CP were used to evaluate neurological function of the patients. Motor development was significantly accelerated within the first month after cell transplantation, but the rate of improvement gradually slowed to preoperative levels. However, after 1 year, the developmental level in each functional sphere (gross motor, fine motor, and cognition) of the treatment group was significantly higher compared to the control group. No delayed complications of this therapy were noted. These results suggest that NPC transplantation is a safe and effective therapeutic method for treating children with severe CP.
More Related Videos
05:04Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
09:29Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
Published on: July 10, 2019